EGLN2 (egl-9 family hypoxia inducible factor 2)

2007-02-01  

Identity

HGNC
LOCATION
19q13.2
LOCUSID
ALIAS
EIT-6,EIT6,HIF-PH1,HIFPH1,HPH-1,HPH-3,PHD1
FUSION GENES

Other Information

Locus ID:

NCBI: 112398
MIM: 606424
HGNC: 14660
Ensembl: ENSG00000269858

Variants:

dbSNP: 112398
ClinVar: 112398
TCGA: ENSG00000269858
COSMIC: EGLN2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000269858ENST00000303961Q96KS0
ENSG00000269858ENST00000303961A0A024R0R2
ENSG00000269858ENST00000406058Q96KS0
ENSG00000269858ENST00000406058A0A024R0R2
ENSG00000269858ENST00000593397M0R1W4
ENSG00000269858ENST00000593525M0QXM8
ENSG00000269858ENST00000593726Q96KS0
ENSG00000269858ENST00000593726A0A024R0R2
ENSG00000269858ENST00000593972M0R0Z6
ENSG00000269858ENST00000594140A0A0C4DGR4
ENSG00000269858ENST00000594380M0R035
ENSG00000269858ENST00000595051M0R1A3
ENSG00000269858ENST00000595621M0R1L0
ENSG00000269858ENST00000596517M0R2X9
ENSG00000269858ENST00000597746M0R350
ENSG00000269858ENST00000598654M0R110
ENSG00000269858ENST00000601733M0QXR0

Expression (GTEx)

0
50
100
150
200
250
300

Pathways

PathwaySourceExternal ID
Renal cell carcinomaKEGGko05211
Pathways in cancerKEGGhsa05200
Renal cell carcinomaKEGGhsa05211
HIF-1 signaling pathwayKEGGhsa04066
Cellular responses to stressREACTOMER-HSA-2262752
Cellular response to hypoxiaREACTOMER-HSA-2262749
Regulation of Hypoxia-inducible Factor (HIF) by oxygenREACTOMER-HSA-1234174
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor AlphaREACTOMER-HSA-1234176

References

Pubmed IDYearTitleCitations
383609972024VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.1
383609972024VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.1
378476872023Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents Hypoxia-Induced pulmonary hypertension.1
378476872023Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents Hypoxia-Induced pulmonary hypertension.1
324586252020Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer.0
324586252020Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer.0
306653272019EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC.20
314145842019Association between an indel polymorphism within the distal promoter of EGLN2 and cancer risk: An updated meta-analysis.1
315006972019Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates.52
317293792019Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer.18
306653272019EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC.20
314145842019Association between an indel polymorphism within the distal promoter of EGLN2 and cancer risk: An updated meta-analysis.1
315006972019Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates.52
317293792019Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer.18
292777912018Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma.3

Citation

Dessen P

EGLN2 (egl-9 family hypoxia inducible factor 2)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46124/egln2